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Abstract 
Deconditioning is a common adverse effect of short and long-term immobilization. For months 
pediatric hematopoietic stem cell transplant patients can be quarantined while hospitalized, 
much of which time is spent immobilized putting these patients at a higher risk for loss of 
muscle strength, functionality, endurance, and quality of life. Studies have shown that exercise 
as an effective countermeasure to deconditioning in stem cell transplant patients. However, 
research is lacking in pediatric HSCT due to the complications associated with treatment. This 
study was conducted to determine if there is a correlation between intrahopsital exercise and 
improved functionality, endurance, strength, and quality of life. In addition, this randomized 
control study looked at the merit and feasibility of adding an exercise routine into treatment 
plans. We have currently recruited 23 of our target 40 patients, 12 in the control arm and 11 in 
the intervention arm, ages 8-17 at Phoenix Children’s Hospital. Each participant received 
baseline measured by an OT or a PT for functionality using (WeeFIM), muscle strength using 
manual muscle testing (MMT), endurance using the 6-minute walk test, and quality of life using 
the NIH PROMIS measures. Measurements were taken again at discharge and 6-weeks post-
discharge. During hospital admittance the intervention group performed exercise routines 3-
times weekly while the control group were encouraged to spend time out of bed. Patients 
recruited were receiving their first HSCT and did not have any post-HSCT complications such as 
severe infection or GVHD. Data and results are limited due to the timepoint of the study and 
the limited number of recruited patients affecting the power of the study. No statistically 
significant difference is noted between the two arms in functional status, muscle strength, or 
endurance. There appears to be an increase in quality of life patients in the interventional arm 
compared to the control arm. Simple analysis has shown that compliance with time out of bed 
decreases across both groups the further away from transplant. Currently the study is midway, 
and data is limited to make any conclusions but shows promise. 
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Introduction/Significance 
Pediatric stem cell transplant patients can be hospitalized for months, quarantined in a clean 
room. Much of this time is spent immobilized in bed. It’s stated that 83% of time is spent in bed 
during a hospital stay [1]. Transplant involves administration of chemotherapy or irradiation 
based conditioning regimen, followed by infusion of hematopoietic stem cells. In addition to 
drug induced toxicities, infections and acute graft versus host disease, reduced physical 
performance and functioning contributes to the early morbidity and mortality (2-4]  Multiple 
studies have shown that muscles, tendons, ligaments, and joints begin to contract and limit 
mobility after only 2-3 weeks of immobilization [5]. During treatment pediatric patients can 
develop dependency for ambulation and transferring due to these effects [6]. Difficulty with 
ambulation due to persistent muscle weakness and fatigue is one of the most common 
complaints of bed rested patients [7]. There is significant reduction in physical activity leading 
to loss of strength and performance and this can be severely debilitating.  
Mobilization and exercise have been studied as a counter measure to these issues.  Studies 
show that functional mobility (walking, standing or sitting up with or without assistance) 
improves fatigue, pain, delirium, DVT, depression, anxiety, and decreased hospital stay duration 
[1].  During the acute phase of a bone marrow transplant rehabilitation exercise was shown in 
one study to help improve outcomes associated with BMT. Rehabilitation correlated with 
improved quality of life (Qol) measures, decreased fatigue, and an increased resolution of 
pancytopenia [6]. Studies conducted by San Juan et al. showed that intra-hospital exercise 
training could improve outcomes as well. However, the exercise program was for survivors after 
treatment [8-9].  There is clear evidence on the benefit of exercise and mobilization for patients 
at risk for deconditioning due to bed rest [10-17]. 
Despite growing numbers of publications describing the effects of these exercise modalities in 
adult HSCT patients, only limited attention has been paid to this effective supportive therapy in 
children. Only four publications describe the effectiveness of exercise training in pediatric 
HSCT[18-20]. San Juan et al. showed beneficial effects on functional performance, muscle 
strength, and Qol scores in a study of children (aged 8–16) undergoing a supervised exercise 
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program that included resistance and aerobic exercises for 3 weeks after HSCT [19]. In another 
study, the moderate intensity exercise program implemented to children undergoing allogeneic 
HSCT for 3 weeks during hospitalization showed positive effects on body mass and body mass 
index (BMI), and no negative effect on immune cell recovery [20]. It was found that a structured 
physical activity program has positive effects on Qol and fatigue scores in children undergoing 
peripheral blood stem cell transplantation. The need for general acceptance of physical activity 
during hospitalization has been shown in this study. [20] 
This study will implement an exercise program that is personalized to hematopoietic stem cell 
transplant recipients designed to prevent a decline in function/independence. We will 
accomplish this by conducting a randomized controlled trial (RCT) that will examine the effect 
of an 8-12 week personalized exercise program compared to standard care following 
hematopoietic stem cell transplantation. Data from this study should increase our 
understanding of the effect of exercise in this population on QoL, functional ability, endurance, 
muscle strength, and fatigue.  
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Research Methods and Materials 
Methods: Patient Selection- Potential patients will be screened for inclusion and exclusion 
criteria as they present to the Phoenix Children’s Hospital Center for Cancer and Blood 
Disorders clinic. Parental or guardian informed consent and child assent, if applicable, will be 
obtained upon admittance and previous to any study related procedures or measurements 
being performed.  
Study Design: 
Forty total patients, ages 5-18, will be recruited and divided randomly into two separate arms 
over an expectant two-year period using block randomization. Their demographic data, BMI, 
Lansky performance, medical and transplant variables will be collected at baseline. Outcome 
variables will be assessed at three stages by the same physiotherapist: at baseline (before HSCT 
procedure), at discharge and 6 weeks after discharge. There is no formal rehabilitation program 
for our pediatric patients during transplant. Both arms will be educated and encouraged to be 
out bed for about four hours daily. In addition, the treatment arm will receive a supervised 
exercise regimen administered by a Physical Therapist. All patients in the study will receive a 
Fitbit upon hospital admittance to track measured steps, continuous HR, active minutes, and 
monitor exercise. Variables in each arm will be measured using the 6-minute walk test, 
WeeFIM, Manual muscle testing, and the NIH PROMIS measures.  
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Table 1. Study Criteria for Recruitment 
Inclusion Criteria 
1) All auto and allogenic transplants 
2) Males or females age 4 to 18 years 
3) Girls ≥ 11 years of age must have a 
negative urine/serum pregnancy test 
4) Parental/guardian permission 
(informed consent) and child assent 
Exclusion Criteria 
1) Previous Stem Cell Transplant in the 
last 6 months 
2) Subjects with any preexisting need for 
gait assistance such as crutches, 
wheelchair, braces, or walker 
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Figure 1. Study Timeline Flowchart 
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PROMIS Measures: Patient Reported Outcomes Measurement Information System (PROMIS) 
is a tool funded in 2007 by the National Institute of Health (NIH) to evaluate the health of adults 
or children in physical, mental, and social categories [21]. Each category is further divided into 
domains. The testing can be administered via short forms or Computer Adaptive Tests (CATs). 
The pediatric assessments can be either self-reported (ages 8-17) or parent proxy-reported 
(ages 5-17 or according to need) [22]. This allows for measurement of health related quality of 
life.  Scoring is done using T-scores with 50 as the mean and a standard deviation of 10. These 
PROMIS measures have been shown to be reliable and precise. [23]  Specifically, in pediatric 
cancer patients, it has been shown that not only is it feasible to administer and complete, but it 
is valid. The short forms have also been shown previously to have a reliability of 0.85 or greater 
over 2-4 standard deviations. [24]. We will use the already composed collection of short forms 
from multiple domains called Profile 49 v2.0. This contains short forms from 8 domains: 
anxiety, depressive symptoms, pain interference, fatigue,  physical function-mobility, peer 
relationships, and pain intensity. [25-30]  
6MWT: The 6MWT is commonly used in measuring exercise capacity and endurance. It has 
been proven validated, safe and reliable. It has also been shown to be useful in cancer patients 
[31-33]. Normative distance values have also been produced for pediatrics in multiple studies 
[32, 34). According to the American Thoracic Society (ATS) they recommend performing the test 
in a straight, 30 m (100-ft) hallway. However, lengths as short as 15 m and as long as 50 m were 
shown to have no significant effect on the results [35-36]. The patient is to sit still for 10 
minutes in a chair before starting the 6MWT. Their vitals and the Borg scale ratings for fatigue 
and dyspnea should be observed. Cones or markers are place every 3m and at the turnaround 
points. These are used for measuring the distance when the patient stops at the end of 6 
minutes. When the patient reaches the starting line and turns to continue the administrator 
makes a clear check mark to keep track and encourage the participant. However, during the 
test the administrator is not allowed to vocally motivate the patient. They are allowed, 
however, to speak in an even tone when sharing the time combined with standard phrases of 
encouragement. The total distance walked is called the 6 Minute Walking Distance (6MWD) and 
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is rounded to the nearest meter. ATS provides a standard form for sue during the 6MWT [31, 
35-36]. 
WeeFIM: The WeeFIM is a widely used and reliable tool used in pediatric studies to measure 
functionality. It consists of normative value sets. It contains 18 different functional items 
divided across three domains: self-care, mobility, and cognition. Each area is rated from 1-7 
using observation or interview with 7 being the highest functional level. It is recommended for 
patients between 6 months and 7 years and between age 6 and 21 who have functional 
limitations expected of a 7-year-old. [37-39] 
MMT: MMT has widely been known to be useful, valid, and reliable in measuring muscle 
strength [40]. Muscle strength is measured against gravity and also against manual resistance. 
Each muscle group is tested and rated from 0 with no palpable muscle contraction to 5 or 
holding position against maximal resistance [40]. 
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Table 2. MMT Grading 
Manual 
Muscle 
Test Score 
Title Percentile Value Descriptive Explanation 
5 Normal(N) 100% Holds test position against maximal resistance 
4 Good(G) 80% Holds test position against moderate resistance 
3 Fair (F) 50% Holds test position against gravity 
2 Poor(P) 20% Able to move through full ROM gravity eliminated 
1 Trace(T) 5% 
No visible movement; palpable or 
observable tendon prominence/flicker 
contraction 
0 0 0% No palpable or observable muscle contraction 
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Exercise Intervention 
This structured exercise program consists of strengthening, endurance, stretching and 
relaxation exercises tailored according to age and their ability to perform activities throughout 
their hospitalization. This exercise program will be done three times a week for 30-45mins 
supervised by the same physiotherapist throughout hospitalization and will be self-
administered every weekend. A printed-out home exercise program with the appropriate 
resistance will be provided to family upon discharge, with instructions on how often to 
complete throughout the week. The family and patient will also be provided a weekly sheet to 
check off the days they completed strengthening and endurance exercises. 
Age 4-6 years 
The goal of the exercise regimen is to target lower extremity, core and upper extremity 
strengthening as well as activity tolerance.  With supervision by the PT, the patient will 
ambulate throughout their room, and complete the following throughout play: squat, single leg 
stance, climb onto couch, half kneel to stand, quadruped and tall kneeling. 
Age 7-21 years 
There will be two components of the exercise program completed by the patients in this age 
group. The first component will be strengthening exercises that will be completed in bed or on 
a mat while sitting or standing. Multiple levels of strengthening exercises will be available, so 
that the exercise program can be tailored to each patient and to their ability to perform 
activities throughout their hospitalization.  The strengthening exercises included will focus on 
core, hip musculature, and upper extremity strengthening; including exercises in quadruped 
and prone positioning, as well as supine, sitting and standing. Thera-Band will be used to 
increase resistance as needed for any exercise. The second component will be endurance 
activities.  Since the patients will be confined to their room for most of their hospitalization this 
will include ambulation within the room, recumbent or pedal exerciser and step ups. 
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Results 
Demographics 
Current recruitment for our study shows a fairly even demographic split for ages and sex 
between the two groups. Of our current 23 patients recruited, the average age is 12 for the 
control group and 15 for the intervention group. The Interquartile range is listed for each group 
is listed in table 1 below. The sex and their ratio are also listed in table 3. There is also an 
appropriate spit between non-malignant and malignant diagnosis for each arm; there is a 50% 
split in each diagnosis among the control arm while the intervention arm had 36.4% non-
malignant diagnosis and 63.6% malignant diagnosis in the intervention arm. The majority of 
transplants in each group were allogeneic.  
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Table 3. Demographics of recruited patients. 
Variables 
Overall 
N=23 
Control 
N=12 
Intervention 
N=11 
Age, Years (median, 
IQR) 14 (7, 16) 12 (7, 15.5) 15 (10, 17) 
Sex (male, %) 
       (Female, %) 
10 (43.5) 
13 (56.5) 
6 (50.0) 
6(50.0) 
4 (36.4) 
7 (63.6) 
Diagnosis (%)  
Non-Malignant 
Malignant  
 
10 (43.5) 
13 (56.5) 
 
6 (50.0) 
6 (50.0) 
 
4 (36.4) 
7 (63.6) 
Type of Transplant 
Autologous 
Allogeneic 
 
3 
20 
 
1 
11 
 
2 
9 
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Functionality 
Functionality was measured using the standardized WeeFIM measurements. The results from 
these measurements are limited at the study midpoint and any statistically significant 
difference is challenging to measure at this point of the study. Graph 1 shows the difference 
between the two group’s means and their changes over the three time points. The intervention 
arm shows a decrease at discharge but an increase back to slightly above the starting mean at 
post-6 week discharge. The control group shows a gradual increase over the entire study with 
the greatest increase coming between discharge and post-6 weeks discharge.   
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Figure 2. WeeFIM Mean (95% CI) stratified by Intervention vs Control, ascertained by the 
Linear Mixed Effects Model controlling for time, age and gender. 
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Endurance 
Graph 2 illustrates the change in the 6-min walk test means over the study time period for both 
groups. The control group started with a better baseline than the intervention arm and showed 
an increase between admit and discharge. It then leveled off between discharge and post-6 
week discharge follow-up. The intervention showed only a minimal, yet gradual, increase in 
6MWT means over the study period.   
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Figure 3. 6MWT distance Mean (95% CI) stratified by Intervention vs Control, ascertained 
by the Linear Mixed Effects Model controlling for time, age and gender. 
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Muscle Strength 
Manual Muscle Testing did not show any major statistically significant differences between the 
two arms. Only two muscle groups tested approach a statistically significant difference: left 
knee extension had a p-value of 0.08 while right ankle plantarflexion had a p-value of 0.09. 
Table 4 below illustrates the change in aggregate means between the groups. Both research 
arms illustrated a change over the study period. 
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Table 4. Change in aggregate MMT means in both groups 
Questions Baseline N=23 
Discharge 
N=19 
6 Week  
Follow-up 
N=14 
P-value 
 Mean (SD) Mean (SD) Mean (SD)  
L Knee Extension 4.72 (0.55) 4.84 (0.37) 4.92 (0.27) 0.08 
R Ankle plantarflexion 4.66 (0.73) 4.31 (1.06) 4.57 (0.85) 0.09 
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A Mixed linear model comparing the intervention arm to the control arm showed deceased 
strength for the intervention arm. Statistically significant values were seen in the right hip 
flexion, left hip abduction, left knee flexion, right knee extension, and left knee extension.  Left 
elbow flexion, left hip extension, and right knee flexion each approached a statistically 
significant decrease.  
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Table 5. Mixed Linear Model of MMT between intervention arm to control 
Muscle Group Beta (95% CI) P-value 
L Elbow Flexion -0.24 (-0.53, 0.04) 0.09 
R Hip flexion -0.37 (-0.69, -0.05) 0.02 
L Hip abduction -0.44 (-0.86, -0.03) 0.04 
L Hip Extension -0.52 (-1.12, 0.09) 0.09 
R Knee Flexion -0.26 (-0.55, 0.03) 0.08 
L Knee Flexion -0.43 (-0.85, -0.02) 0.04 
R Knee Extension -0.47 (-0.82, -0.12) 0.009 
L Knee Extension -0.45 (-0.76, -0.13) 0.005 
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Quality of Life 
Table 6 above illustrates the aggregate means of both means for the PROMIS measure 
decreased over the study timeline. The categories I felt nervous, I felt worried, I got scared 
really easy, and I felt weak each showed a statistically significant decrease over the time period. 
The other above listed categories approached statistical significance.   
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Table 6.  Change in Aggregate PROMIS Measure Means in Both Groups 
Questions Baseline N=23 
Discharge 
N=19 
6 Week  
Follow-up 
N=14 
P-value 
 Mean (SD) Mean (SD) Mean (SD)  
I felt nervous 2.58 (0.79) 2.00 (1.15) 1.20 (0.45) 0.001 
I felt worried 2.33 (1.07) 2.25 (1.50) 1.20 (0.45) 0.007 
I got scared really easy 1.67 (0.78) 1.25 (0.50) 1.0 (0.0) 0.04 
I was too tired to do 
sports or exercise 2.00 (0.95) 1.33 (0.58) 1.75 (0.96) 0.08 
I felt weak 2.17 (1.03) 2.00 (1.15) 1.20 (0.45) 0.01 
I had trouble finishing 
things because I was too 
tired 
2.08 (0.79) 2.75 (0.50) 1.40 (0.55) 0.05 
I had trouble starting 
things because I was too 
tired 
1.75 (0.87) 2.00 (1.15) 1.40 (0.55) 0.07 
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Compliance 
Compliance was also studied and showed a decrease in compliance with recording and 
spending time out of bed. The further out from transplant the less likely patients were likely to 
maintain their compliance with recording time out of bed, which is illustrated by Graph 3 
below. There was a 50% decrease in compliance from week 1 to week 6 of hospitalization.   
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Figure 4. Compliance Percent Overall Compliance of Time Out of Bed. 
  
 24 
Discussion 
The current pilot study is only half way through its projected trajectory of 40 patients. Having 
only recruited 23 patients makes it challenging to draw conclusions based on the small number 
recruited and small sample size. However, even though changes are noted between the two 
arms, no real statistically significant difference has been seen between the intervention and 
control arms in functionality, endurance, and strength at this stage of the study. There is an 
increase in both function and endurance in both arms while there seems to be a decrease in 
strength in both groups. There appears to be  better quality of life in patients in the 
interventional arm compared to the control arm. Compliance with getting out of bed gradually 
decreases the longer they stay in the hospital which makes is not surprising.  
The data is slowly taking shape and appears promising once more subjects are recruited. With a 
larger sample size, a better comparison between the two groups will be possible; it will be 
possible to directly compare both groups rather then look at their aggregate means. The study 
is still ongoing and will estimated to be complete by September of 2019.  
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Future Directions 
This study has proven as a good first step in the direction of decreasing deconditioning in 
pediatric stem cell transplant patients. However, this study was limited by time and by the 
number of patients recruited. At this point the project is only half-way completed and will end 
with a total of 40 patients. It serves as a pilot study which will need further exploration to fully 
determine exercise’s role the transplant process. A large-scale, multi-facility study would be 
ideal to better distinguish the promising effects this study touches on.  
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Conclusions 
Due to the expected mid-study limited sample size it unlikely that any conclusions can be 
drawn. However, it can be concluded that the data being collected is promising and that the 
pilot study holds promise. It can also be concluded that the methodology of the study appears 
to be effective and no adjustments to the study need to be made at this point. It could be 
assumed from the data that compliance decreases with time but still data is limited making a 
conclusion about compliance not possible. The study needs to be continued and finished to 
show any true conclusions. Even then a larger study might need to be conducted to truly get a 
better understanding of the possible benefits and treatment altering effects that exercise can 
have on pediatric stem cell transplant patients.  
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